SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NIGMS
Grant: #SC2GM141720
NIH/NIGMS
Grant: #P20GM103475
NIH/NIGMS
Grant: #P0315130068
NIH/NIGMS
Grant: #HRD-2008186
NIH/NIGMS
Grant: #SC3GM111171
NIH/NIGMS
Grant: #U54GM133807
NIGMS NIH HHS
Grant: SC3 GM111171
NIH HHS
Grant: P20GM103475
NIH HHS
Grant: SC2GM141720
NIH HHS
Grant: U54GM133807
National Institutes of Health
Grant: 5U54GM133807-02
Hispanic Alliance for Clinical and Translational Research (Alliance)
National Institutes of Health
Grant: 5SC3GM111171-04
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi
National Institutes of Health
Grant: 5SC2GM141720-02
SCAMP3 as a regulator of EGFR/STAT3 axis in triple-negative breast cancer
National Institutes of Health
Grant: 5P20GM103475-16
Advancing Competitive Biomedical Research in Puerto Rico
FWCI
0.94
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals